Study wrapper · #263
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs.
Editor's note
Two framing points matter most here. First, this is a preprint posted on Research Square - it has not yet been peer-reviewed, so its findings should be treated as provisional. Second, it is an animal study in aged mice, making it a mechanistic signal rather than clinical proof. Within those limits it is a genuinely interesting efficacy-and-mechanism study: aged mice given GHK-Cu either short-term intraperitoneally or longer-term intranasally both showed improved performance on a hippocampal-dependent spatial-learning task, but the two routes engaged strikingly different molecular programs on RNA sequencing - intranasal dosing suppressed growth and mitochondrial-metabolic signalling, while intraperitoneal dosing activated stress-response and DNA-repair pathways. The behavioural benefit was more consistent and sustained with the intranasal route. The takeaway that route and duration shape the biological response is a useful hypothesis. But this is unreplicated, not yet peer-reviewed, and in rodents; human cognitive data for GHK-Cu do not exist. Read it as an early lead, not a conclusion.
Plain-language abstract
This animal study asked whether the copper peptide GHK-Cu could improve age-related memory decline in old mice, and whether the way it is given matters. Aged mice (about 20-21 months old) received GHK-Cu either as a short 5-day course injected into the abdomen, or as a longer 8-week course delivered through the nose. Researchers tested the mice on a spatial learning task that depends on the hippocampus (a memory-related brain region) and examined brain tissue and gene activity. The nasal route improved learning in both male and female mice and did so consistently, while the abdominal injections produced only a brief improvement in males and none in females. Gene-activity analysis showed the two routes worked through very different biological programs: nasal dosing quieted growth and energy-metabolism pathways linked to ageing, while abdominal dosing switched on stress-response and DNA-repair pathways. The authors concluded that both the delivery route and the length of treatment strongly shape the response. Important cautions: this is a preprint that has not yet been peer-reviewed, and it was done in mice - human data would be needed before drawing any conclusions about memory in people.